Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D2CY
|
|||
| Former ID |
DIB012717
|
|||
| Drug Name |
DEX-M74
|
|||
| Synonyms |
Hereditary inclusion body myopathy therapy, National Human Genome Research Institute/ New Zealand Pharmaceuticals
Click to Show/Hide
|
|||
| Indication | Myopathy [ICD-11: 8C7Y] | Phase 1/2 | [1] | |
| Company |
National Human Genome Research Institute
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02346461) An Open Label Phase 2 Study of DEX-M74 in Subjects With GNE Myopathy. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.